| Year |
Citation |
Score |
| 2023 |
Collingridge GL, Evans RH, Jane DE, Lodge D. Jeffrey Clifton Watkins FRS - The father of the glutamate receptor. Neuropharmacology. 109650. PMID 37474350 DOI: 10.1016/j.neuropharm.2023.109650 |
0.672 |
|
| 2022 |
Birnie MT, Eapen AV, Kershaw YM, Lodge D, Collingridge GL, Conway-Campbell BL, Lightman SL. Time of day influences stress hormone response to ketamine. Journal of Neuroendocrinology. e13194. PMID 36056546 DOI: 10.1111/jne.13194 |
0.427 |
|
| 2021 |
Frenguelli B, Lodge D, Rammes G, Collingridge G, Quack G, Jerecic J, Headley M, Danysz W. A tribute to Chris Parsons. Neuropharmacology. 195: 108633. PMID 34198024 DOI: 10.1016/j.neuropharm.2021.108633 |
0.332 |
|
| 2020 |
Kang H, Park P, Han M, Tidball P, Georgiou J, Bortolotto ZA, Lodge D, Kaang BK, Collingridge GL. (2,6)- and (2,6)-hydroxynorketamine inhibit the induction of NMDA receptor-dependent LTP at hippocampal CA1 synapses in mice. Brain and Neuroscience Advances. 4: 2398212820957847. PMID 33088919 DOI: 10.1177/2398212820957847 |
0.833 |
|
| 2019 |
Wallach J, Colestock T, Agramunt J, Claydon MDB, Dybek M, Filemban N, Chatha M, Halberstadt AL, Brandt SD, Lodge D, Bortolotto ZA, Adejare A. Pharmacological characterizations of the legal high fluorolintane and isomers. European Journal of Pharmacology. 172427. PMID 31152702 DOI: 10.1016/J.Ejphar.2019.172427 |
0.763 |
|
| 2018 |
Lodge D, Watkins JC, Bortolotto ZA, Jane DE, Volianskis A. The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries. Neurochemical Research. PMID 30284673 DOI: 10.1007/S11064-018-2640-6 |
0.797 |
|
| 2018 |
Wood CM, Wafford KA, McCarthy AP, Hewes N, Shanks E, Lodge D, Robinson ES. Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression. Neuropharmacology. PMID 30005976 DOI: 10.1016/j.neuropharm.2018.07.013 |
0.377 |
|
| 2018 |
Ingram R, Kang H, Lightman S, Jane DE, Bortolotto ZA, Collingridge GL, Lodge D, Volianskis A. Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology. PMID 29885421 DOI: 10.1016/J.Neuropharm.2018.06.008 |
0.821 |
|
| 2017 |
Mastroiacovo F, Moyanova S, Cannella M, Gaglione A, Verhaeghe R, Bozza G, Madonna M, Motolese M, Traficante A, Riozzi B, Bruno V, Battaglia G, Lodge D, Nicoletti F. Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia. Molecular Brain. 10: 39. PMID 28821279 DOI: 10.1186/s13041-017-0319-6 |
0.519 |
|
| 2016 |
Collingridge GL, Lee Y, Bortolotto ZA, Kang H, Lodge D. Antidepressant Actions of Ketamine Versus Hydroxynorketamine. Biological Psychiatry. PMID 27817845 DOI: 10.1016/j.biopsych.2016.06.029 |
0.658 |
|
| 2016 |
Collingridge GL, Lodge D, Mayer M, Turrigiano G, Frenguelli BG. Ionotropic glutamate receptors: still exciting after all these years. Neuropharmacology. PMID 27659748 DOI: 10.1016/J.Neuropharm.2016.09.019 |
0.666 |
|
| 2016 |
Kang H, Park P, Bortolotto ZA, Brandt SD, Colestock T, Wallach J, Collingridge GL, Lodge D. Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology. PMID 27520396 DOI: 10.1016/j.neuropharm.2016.08.004 |
0.817 |
|
| 2016 |
Wallach J, Kang H, Colestock T, Morris H, Bortolotto ZA, Collingridge GL, Lodge D, Halberstadt AL, Brandt SD, Adejare A. Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues. Plos One. 11: e0157021. PMID 27314670 DOI: 10.1371/Journal.Pone.0157021 |
0.734 |
|
| 2016 |
Wood CM, Nicolas CS, Choi SL, Roman E, Nylander I, Fernandez-Teruel A, Kiianmaa K, Bienkowski P, de Jong TR, Colombo G, Chastagnier D, Wafford KA, Collingridge GL, Wildt SJ, Conway-Campbell BL, ... ... Lodge D, et al. Prevalence and influence of cys407* Grm2 mutation in Hannover-derived Wistar rats: mGlu2 receptor loss links to alcohol intake, risk taking and emotional behaviour. Neuropharmacology. PMID 26987983 DOI: 10.1016/j.neuropharm.2016.03.020 |
0.658 |
|
| 2015 |
Wallis JL, Irvine MW, Jane DE, Lodge D, Collingridge GL, Bortolotto ZA. An interchangeable role for kainate and metabotropic glutamate receptors in the induction of rat hippocampal mossy fiber long-term potentiation in vivo. Hippocampus. PMID 25821051 DOI: 10.1002/Hipo.22460 |
0.834 |
|
| 2015 |
Wallach J, Kavanagh PV, McLaughlin G, Morris N, Power JD, Elliott SP, Mercier MS, Lodge D, Morris H, Dempster NM, Brandt SD. Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers. Drug Testing and Analysis. 7: 358-67. PMID 25044512 DOI: 10.1002/dta.1689 |
0.351 |
|
| 2014 |
Mercier MS, Lodge D. Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential. Neurochemical Research. 39: 1876-94. PMID 25146900 DOI: 10.1007/s11064-014-1415-y |
0.602 |
|
| 2013 |
Lodge D, Tidball P, Mercier MS, Lucas SJ, Hanna L, Ceolin L, Kritikos M, Fitzjohn SM, Sherwood JL, Bannister N, Volianskis A, Jane DE, Bortolotto ZA, Collingridge GL. Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors. Neuropharmacology. 74: 135-46. PMID 23542080 DOI: 10.1016/J.Neuropharm.2013.03.011 |
0.81 |
|
| 2013 |
Crabtree JW, Lodge D, Bashir ZI, Isaac JT. GABAA , NMDA and mGlu2 receptors tonically regulate inhibition and excitation in the thalamic reticular nucleus. The European Journal of Neuroscience. 37: 850-9. PMID 23294136 DOI: 10.1111/ejn.12098 |
0.664 |
|
| 2013 |
Mercier MS, Lodge D, Fang G, Nicolas CS, Collett VJ, Jane DE, Collingridge GL, Bortolotto ZA. Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus. Neuropharmacology. 67: 294-303. PMID 23220400 DOI: 10.1016/J.Neuropharm.2012.11.020 |
0.807 |
|
| 2013 |
Collingridge GL, Volianskis A, Bannister N, France G, Hanna L, Mercier M, Tidball P, Fang G, Irvine MW, Costa BM, Monaghan DT, Bortolotto ZA, Molnár E, Lodge D, Jane DE. The NMDA receptor as a target for cognitive enhancement. Neuropharmacology. 64: 13-26. PMID 22796429 DOI: 10.1016/J.Neuropharm.2012.06.051 |
0.798 |
|
| 2013 |
Sanger H, Hanna L, Colvin EM, Grubisha O, Ursu D, Heinz BA, Findlay JD, Vivier RG, Sher E, Lodge D, Monn JA, Broad LM. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR. Neuropharmacology. 66: 264-73. PMID 22659090 DOI: 10.1016/j.neuropharm.2012.05.023 |
0.571 |
|
| 2013 |
Lucas SJ, Bortolotto ZA, Collingridge GL, Lodge D. Selective activation of either mGlu2 or mGlu3 receptors can induce LTD in the amygdala. Neuropharmacology. 66: 196-201. PMID 22531751 DOI: 10.1016/j.neuropharm.2012.04.006 |
0.828 |
|
| 2013 |
Hanna L, Ceolin L, Lucas S, Monn J, Johnson B, Collingridge G, Bortolotto Z, Lodge D. Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist. Neuropharmacology. 66: 114-21. PMID 22445601 DOI: 10.1016/j.neuropharm.2012.02.023 |
0.812 |
|
| 2012 |
Sherwood JL, Amici M, Dargan SL, Culley GR, Fitzjohn SM, Jane DE, Collingridge GL, Lodge D, Bortolotto ZA. Differences in kainate receptor involvement in hippocampal mossy fibre long-term potentiation depending on slice orientation. Neurochemistry International. 61: 482-9. PMID 22564530 DOI: 10.1016/J.Neuint.2012.04.021 |
0.843 |
|
| 2012 |
Ceolin L, Bortolotto ZA, Bannister N, Collingridge GL, Lodge D, Volianskis A. A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochemistry International. 61: 517-22. PMID 22433907 DOI: 10.1016/j.neuint.2012.02.035 |
0.803 |
|
| 2012 |
Lodge DJ, Grace AA. Gestational methylazoxymethanol acetate administration alters proteomic and metabolomic markers of hippocampal glutamatergic transmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 319-20. PMID 22157947 DOI: 10.1038/npp.2011.255 |
0.31 |
|
| 2011 |
Ceolin L, Kantamneni S, Barker GR, Hanna L, Murray L, Warburton EC, Robinson ES, Monn JA, Fitzjohn SM, Collingridge GL, Bortolotto ZA, Lodge D. Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotype. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 6721-31. PMID 21543601 DOI: 10.1523/JNEUROSCI.0418-11.2011 |
0.857 |
|
| 2010 |
Huang LT, Sherwood JL, Sun YJ, Lodge D, Wang Y. Activation of presynaptic alpha7 nicotinic receptors evokes an excitatory response in hippocampal CA3 neurones in anaesthetized rats: an in vivo iontophoretic study. British Journal of Pharmacology. 159: 554-65. PMID 20105181 DOI: 10.1111/j.1476-5381.2009.00529.x |
0.747 |
|
| 2009 |
Nisticò R, Dargan S, Fitzjohn SM, Lodge D, Jane DE, Collingridge GL, Bortolotto ZA. GLUK1 receptor antagonists and hippocampal mossy fiber function. International Review of Neurobiology. 85: 13-27. PMID 19607958 DOI: 10.1016/S0074-7742(09)85002-2 |
0.861 |
|
| 2009 |
Jane DE, Lodge D, Collingridge GL. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology. 56: 90-113. PMID 18793656 DOI: 10.1016/J.Neuropharm.2008.08.023 |
0.71 |
|
| 2009 |
Dargan SL, Clarke VR, Alushin GM, Sherwood JL, Nisticò R, Bortolotto ZA, Ogden AM, Bleakman D, Doherty AJ, Lodge D, Mayer ML, Fitzjohn SM, Jane DE, Collingridge GL. ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function. Neuropharmacology. 56: 121-30. PMID 18789344 DOI: 10.1016/J.Neuropharm.2008.08.016 |
0.847 |
|
| 2009 |
Lodge D. The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology. 56: 6-21. PMID 18765242 DOI: 10.1016/j.neuropharm.2008.08.006 |
0.638 |
|
| 2007 |
Bartlett TE, Bannister NJ, Collett VJ, Dargan SL, Massey PV, Bortolotto ZA, Fitzjohn SM, Bashir ZI, Collingridge GL, Lodge D. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology. 52: 60-70. PMID 16904707 DOI: 10.1016/J.Neuropharm.2006.07.013 |
0.87 |
|
| 2006 |
Wang Y, Sherwood JL, Lodge D. The alpha4beta2 nicotinic acetylcholine receptor agonist TC-2559 impairs long-term potentiation in the dentate gyrus in vivo. Neuroscience Letters. 406: 183-8. PMID 16935422 DOI: 10.1016/j.neulet.2006.06.075 |
0.759 |
|
| 2006 |
Djouma E, Card K, Lodge DJ, Lawrence AJ. The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats. The European Journal of Neuroscience. 23: 3319-27. PMID 16820021 DOI: 10.1111/j.1460-9568.2006.04864.x |
0.33 |
|
| 2006 |
Wang Y, Sherwood JL, Miles CP, Whiffin G, Lodge D. TC-2559 excites dopaminergic neurones in the ventral tegmental area by stimulating alpha4beta2-like nicotinic acetylcholine receptors in anaesthetised rats. British Journal of Pharmacology. 147: 379-90. PMID 16402043 DOI: 10.1038/sj.bjp.0706621 |
0.674 |
|
| 2006 |
Takeuchi K, Kohn TJ, Honigschmidt NA, Rocco VP, Spinazze PG, Hemrick-Luecke SK, Thompson LK, Evans DC, Rasmussen K, Koger D, Lodge D, Martin LJ, Shaw J, Threlkeld PG, Wong DT. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5. Bioorganic & Medicinal Chemistry Letters. 16: 2347-51. PMID 16298130 DOI: 10.1016/j.bmcl.2005.11.007 |
0.397 |
|
| 2006 |
Kingston AE, O'Neill MJ, Bond A, Jordan WH, Tizzano JP, Griffey KI, Johnson JA, Jones N, Monn JA, Lodge D, Schoepp DD. Neuroprotective Actions of Novel and Potent Agonists of Group II Metabotropic Glutamate Receptors Cns Drug Reviews. 6: 36-37. DOI: 10.1111/j.1527-3458.2000.tb00180.x |
0.486 |
|
| 2004 |
Smolders I, Lindekens H, Clinckers R, Meurs A, O'Neill MJ, Lodge D, Ebinger G, Michotte Y. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands. Journal of Neurochemistry. 88: 1068-77. PMID 15009663 DOI: 10.1046/j.1471-4159.2003.02251.x |
0.5 |
|
| 2003 |
Lodge DJ, Lawrence AJ. The effect of chronic CRF1 receptor blockade on the central CCK systems of Fawn-Hooded rats. Regulatory Peptides. 116: 27-33. PMID 14599712 DOI: 10.1016/S0167-0115(03)00189-7 |
0.365 |
|
| 2003 |
Lodge DJ, Roques BP, Lawrence AJ. Atypical behavioural responses to CCK-B receptor ligands in Fawn-Hooded rats. Life Sciences. 74: 1-12. PMID 14575808 DOI: 10.1016/j.lfs.2003.03.003 |
0.368 |
|
| 2003 |
Lauri SE, Bortolotto ZA, Nistico R, Bleakman D, Ornstein PL, Lodge D, Isaac JT, Collingridge GL. A role for Ca2+ stores in kainate receptor-dependent synaptic facilitation and LTP at mossy fiber synapses in the hippocampus. Neuron. 39: 327-41. PMID 12873388 DOI: 10.1016/S0896-6273(03)00369-6 |
0.818 |
|
| 2003 |
Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, et al. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 306: 752-62. PMID 12730350 DOI: 10.1124/Jpet.103.049445 |
0.482 |
|
| 2002 |
Smolders I, Bortolotto ZA, Clarke VR, Warre R, Khan GM, O'Neill MJ, Ornstein PL, Bleakman D, Ogden A, Weiss B, Stables JP, Ho KH, Ebinger G, Collingridge GL, Lodge D, et al. Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures. Nature Neuroscience. 5: 796-804. PMID 12080343 DOI: 10.1038/Nn880 |
0.76 |
|
| 2002 |
Sharpe EF, Kingston AE, Lodge D, Monn JA, Headley PM. Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo. British Journal of Pharmacology. 135: 1255-62. PMID 11877334 DOI: 10.1038/sj.bjp.0704583 |
0.318 |
|
| 2001 |
Lauri SE, Bortolotto ZA, Bleakman D, Ornstein PL, Lodge D, Isaac JT, Collingridge GL. A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP. Neuron. 32: 697-709. PMID 11719209 DOI: 10.1016/S0896-6273(01)00511-6 |
0.828 |
|
| 2001 |
Vandergriff J, Huff K, Bond A, Lodge D. Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo. Neuropharmacology. 40: 1003-9. PMID 11406191 DOI: 10.1016/S0028-3908(01)00031-4 |
0.454 |
|
| 2001 |
Bortolotto ZA, Clarke VRJ, Delany CM, Parry MC, Smolders I, Vignes M, Ho KH, Miu P, Brinton BT, Fantaske R, Ogden A, Gates M, Ornstein PL, Lodge D, Bleakman D, et al. Erratum: correction: Kainate receptors are involved in synaptic plasticity Nature. 409: 542-542. DOI: 10.1038/35054109 |
0.8 |
|
| 2000 |
Doherty AJ, Palmer MJ, Bortolotto ZA, Hargreaves A, Kingston AE, Ornstein PL, Schoepp DD, Lodge D, Collingridge GL. A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices. British Journal of Pharmacology. 131: 239-44. PMID 10991916 DOI: 10.1038/Sj.Bjp.0703574 |
0.816 |
|
| 1999 |
Kingston AE, O'Neill MJ, Bond A, Bruno V, Battaglia G, Nicoletti F, Harris JR, Clark BP, Monn JA, Lodge D, Schoepp DD. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors. Annals of the New York Academy of Sciences. 890: 438-49. PMID 10668448 DOI: 10.1111/j.1749-6632.1999.tb08022.x |
0.479 |
|
| 1999 |
Bortolotto ZA, Clarke VR, Delany CM, Parry MC, Smolders I, Vignes M, Ho KH, Miu P, Brinton BT, Fantaske R, Ogden A, Gates M, Ornstein PL, Lodge D, Bleakman D, et al. Kainate receptors are involved in synaptic plasticity. Nature. 402: 297-301. PMID 10580501 DOI: 10.1038/46290 |
0.823 |
|
| 1999 |
Fitzjohn SM, Kingston AE, Lodge D, Collingridge GL. DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists. Neuropharmacology. 38: 1577-83. PMID 10530819 DOI: 10.1016/S0028-3908(99)00123-9 |
0.849 |
|
| 1999 |
Cushing A, Price-Jones MJ, Graves R, Harris AJ, Hughes KT, Bleakman D, Lodge D. Measurement of calcium flux through ionotropic glutamate receptors using Cytostar-T scintillating microplates. Journal of Neuroscience Methods. 90: 33-6. PMID 10517271 DOI: 10.1016/S0165-0270(99)00058-8 |
0.46 |
|
| 1999 |
Bond A, Ragumoorthy N, Monn JA, Hicks CA, Ward MA, Lodge D, O'Neill MJ. LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia. Neuroscience Letters. 273: 191-4. PMID 10515191 DOI: 10.1016/S0304-3940(99)00663-1 |
0.326 |
|
| 1999 |
Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. European Journal of Pharmacology. 380: 91-9. PMID 10513567 DOI: 10.1016/S0014-2999(99)00523-3 |
0.477 |
|
| 1998 |
Fitzjohn SM, Bortolotto ZA, Palmer MJ, Doherty AJ, Ornstein PL, Schoepp DD, Kingston AE, Lodge D, Collingridge GL. The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology. 37: 1445-58. PMID 9886667 DOI: 10.1016/S0028-3908(98)00145-2 |
0.875 |
|
| 1998 |
Ornstein PL, Arnold MB, Lunn WH, Heinz LJ, Leander JD, Lodge D, Schoepp DD. Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonists. Bioorganic & Medicinal Chemistry Letters. 8: 389-94. PMID 9871691 DOI: 10.1016/S0960-894X(98)00038-9 |
0.512 |
|
| 1998 |
Procter MJ, Houghton AK, Faber ES, Chizh BA, Ornstein PL, Lodge D, Headley PM. Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord. Neuropharmacology. 37: 1287-97. PMID 9849666 DOI: 10.1016/S0028-3908(98)00136-1 |
0.447 |
|
| 1998 |
Vignes M, Clarke VR, Parry MJ, Bleakman D, Lodge D, Ornstein PL, Collingridge GL. The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus. Neuropharmacology. 37: 1269-77. PMID 9849664 DOI: 10.1016/S0028-3908(98)00148-8 |
0.682 |
|
| 1998 |
O'Neill MJ, Bond A, Ornstein PL, Ward MA, Hicks CA, Hoo K, Bleakman D, Lodge D. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. Neuropharmacology. 37: 1211-22. PMID 9849659 DOI: 10.1016/S0028-3908(98)00134-8 |
0.51 |
|
| 1998 |
Bleakman D, Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology. 37: 1187-204. PMID 9849657 DOI: 10.1016/S0028-3908(98)00139-7 |
0.542 |
|
| 1998 |
Lam AG, Soriano MA, Monn JA, Schoepp DD, Lodge D, McCulloch J. Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia. Neuroscience Letters. 254: 121-3. PMID 9779935 DOI: 10.1016/S0304-3940(98)00651-X |
0.378 |
|
| 1998 |
Bond A, O'Neill MJ, Hicks CA, Monn JA, Lodge D. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport. 9: 1191-3. PMID 9601692 DOI: 10.1097/00001756-199804200-00042 |
0.45 |
|
| 1998 |
Collingridge GL, Lodge D. 7th Neuropharmacology Conference: Editorial Neuropharmacology. 37: 1185. DOI: 10.1016/S0028-3908(98)00169-5 |
0.336 |
|
| 1997 |
Vignes M, Bleakman D, Lodge D, Collingridge GL. The synaptic activation of the GluR5 subtype of kainate receptor in area CA3 of the rat hippocampus. Neuropharmacology. 36: 1477-81. PMID 9517417 DOI: 10.1016/S0028-3908(97)00158-5 |
0.736 |
|
| 1997 |
Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389: 599-603. PMID 9335499 DOI: 10.1038/39315 |
0.703 |
|
| 1997 |
Bond A, Monn JA, Lodge D. A novel orally active group 2 metabotropic glutamate receptor agonist: LY354740. Neuroreport. 8: 1463-6. PMID 9172154 DOI: 10.1097/00001756-199704140-00027 |
0.487 |
|
| 1997 |
Willis CL, Wacker DA, Bartlett RD, Bleakman D, Lodge D, Chamberlin AR, Bridges RJ. Irreversible inhibition of high-affinity [3H]kainate binding by a novel photoactivatable analogue: (2'S,3'S,4'R)-2'-carboxy-4'-(2-diazo-1-oxo-3, 3,3-trifluoropropyl)-3'-pyrrolidinyl acetate. Journal of Neurochemistry. 68: 1503-10. PMID 9084420 DOI: 10.1046/J.1471-4159.1997.68041503.X |
0.32 |
|
| 1997 |
Gill R, Lodge D. Pharmacology of AMPA antagonists and their role in neuroprotection. International Review of Neurobiology. 40: 197-232. PMID 8989622 DOI: 10.1016/S0074-7742(08)60721-7 |
0.528 |
|
| 1996 |
Bleakman D, Ballyk BA, Schoepp DD, Palmer AJ, Bath CP, Sharpe EF, Woolley ML, Bufton HR, Kamboj RK, Tarnawa I, Lodge D. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology. 35: 1689-702. PMID 9076748 DOI: 10.1016/S0028-3908(96)00156-6 |
0.524 |
|
| 1996 |
Lodge D, Bond A, O'Neill MJ, Hicks CA, Jones MG. Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies. Neuropharmacology. 35: 1681-8. PMID 9076747 DOI: 10.1016/S0028-3908(96)00155-4 |
0.342 |
|
| 1996 |
Nooney JM, Lodge D. The use of invertebrate peptide toxins to establish Ca2+ channel identity of CA3-CA1 neurotransmission in rat hippocampal slices. European Journal of Pharmacology. 306: 41-50. PMID 8813613 DOI: 10.1016/0014-2999(96)00195-1 |
0.351 |
|
| 1996 |
Fletcher EJ, Lodge D. New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacology & Therapeutics. 70: 65-89. PMID 8804111 DOI: 10.1016/0163-7258(96)00014-9 |
0.517 |
|
| 1996 |
Fitzjohn SM, Irving AJ, Palmer MJ, Harvey J, Lodge D, Collingridge GL. Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices. Neuroscience Letters. 203: 211-3. PMID 8742030 DOI: 10.1016/0304-3940(96)12301-6 |
0.788 |
|
| 1996 |
Monn JA, Valli MJ, Johnson BG, Salhoff CR, Wright RA, Howe T, Bond A, Lodge D, Spangle LA, Paschal JW, Campbell JB, Griffey K, Tizzano JP, Schoepp DD. Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase. Journal of Medicinal Chemistry. 39: 2990-3000. PMID 8709133 DOI: 10.1021/jm9601765 |
0.359 |
|
| 1996 |
Ornstein PL, Arnold MB, Allen NK, Bleisch T, Borromeo PS, Lugar CW, Leander JD, Lodge D, Schoepp DD. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity. Journal of Medicinal Chemistry. 39: 2232-44. PMID 8667366 DOI: 10.1021/jm950913h |
0.326 |
|
| 1996 |
Ornstein PL, Arnold MB, Allen NK, Bleisch T, Borromeo PS, Lugar CW, Leander JD, Lodge D, Schoepp DD. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution. Journal of Medicinal Chemistry. 39: 2219-31. PMID 8667365 DOI: 10.1021/jm950912p |
0.349 |
|
| 1996 |
Fitzjohn SM, Lodge D, Collingridge GL. Long-term depression of synaptic transmission induced by group in metabotropic glutamate receptor activation in the CA1 of young rat hippocampus Journal of Physiology Paris. 90: 410-4111. DOI: 10.1016/S0928-4257(97)87937-5 |
0.818 |
|
| 1996 |
Lodge D, Bond A. Spinal glutamate receptors Pharmacochemistry Library. 24: 241-252. DOI: 10.1016/S0165-7208(96)80020-1 |
0.346 |
|
| 1996 |
Lodge D, Monn JA, Bond A, Woolley ML. Interaction between metabotropic and ionotropic glutamate receptors on rat spinal cord in vivo and in vitro Neuropharmacology. 35: A18. DOI: 10.1016/0028-3908(96)84717-4 |
0.308 |
|
| 1996 |
Kingston A, Tomlinson R, Clark B, Harris J, Goldsworthy J, Burnett J, Mayne N, Lodge D. Agonist and antagonist pharmacology of cloned human group 1 mGluRs Neuropharmacology. 35: A17. DOI: 10.1016/0028-3908(96)84713-7 |
0.313 |
|
| 1996 |
Gill R, Lodge D. Pharmacology of AMPA antagonists and their role in neurophotection International Review of Neurobiology. 197-232. |
0.449 |
|
| 1995 |
Schoepp DD, Lodge D, Bleakman D, Leander JD, Tizzano JP, Wright RA, Palmer AJ, Salhoff CR, Ornstein PL. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid. Neuropharmacology. 34: 1159-68. PMID 8532186 DOI: 10.1016/0028-3908(95)00099-R |
0.416 |
|
| 1995 |
Bond A, Lodge D. Pharmacology of metabotropic glutamate receptor-mediated enhancement of responses to excitatory and inhibitory amino acids on rat spinal neurones in vivo. Neuropharmacology. 34: 1015-23. PMID 8532150 DOI: 10.1016/0028-3908(95)00046-9 |
0.337 |
|
| 1995 |
Ornstein PL, Arnold MB, Allen NK, Leander JD, Tizzano JP, Lodge D, Schoepp DD. (3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist. Journal of Medicinal Chemistry. 38: 4885-90. PMID 8523401 |
0.479 |
|
| 1995 |
Collingridge G, Lodge D. Editorial Neuropharmacology. 34: v. |
0.333 |
|
| 1993 |
Ornstein PL, Arnold MB, Augenstein NK, Lodge D, Leander JD, Schoepp DD. (3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist. Journal of Medicinal Chemistry. 36: 2046-8. PMID 8393116 |
0.32 |
|
| 1993 |
Parsons CG, Gruner R, Rozental J, Millar J, Lodge D. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology. 32: 1337-50. PMID 8152525 DOI: 10.1016/0028-3908(93)90029-3 |
0.419 |
|
| 1993 |
Palmer AJ, Lodge D. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. European Journal of Pharmacology. 244: 193-4. PMID 7679352 DOI: 10.1016/0922-4106(93)90027-7 |
0.621 |
|
| 1993 |
Monn JA, Valli MJ, 1 RA, Schoepp DD, Leander JD, Lodge D. Synthesis and pharmacological characterization of l-trans-4-tetrazolylproline (ly300020): A novel systemically-active ampa receptor agonist Bioorganic and Medicinal Chemistry Letters. 3: 95-98. DOI: 10.1016/S0960-894X(00)80099-2 |
0.373 |
|
| 1993 |
Lodge D, Bond A. Pharmacology of ionotropic and metabotropic glutamate receptors European Neuropsychopharmacology. 3: 181-182. DOI: 10.1016/0924-977X(93)90013-C |
0.515 |
|
| 1992 |
Ornstein PL, Schoepp DD, Arnold MB, Augenstein NK, Lodge D, Millar JD, Chambers J, Campbell J, Paschal JW, Zimmerman DM. 6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists. Journal of Medicinal Chemistry. 35: 3547-60. PMID 1404235 |
0.417 |
|
| 1992 |
Ornstein PL, Schoepp DD, Arnold MB, Jones ND, Deeter JB, Lodge D, Leander JD. NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer. Journal of Medicinal Chemistry. 35: 3111-5. PMID 1387167 DOI: 10.1021/Jm00095A004 |
0.328 |
|
| 1992 |
Zeman S, Lodge D. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro. British Journal of Pharmacology. 106: 367-72. PMID 1382781 |
0.475 |
|
| 1992 |
McQuaid LA, Smith EC, South KK, Mitch CH, Schoepp DD, True RA, Calligaro DO, O'Malley PJ, Lodge D, Ornstein PL. Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones. Journal of Medicinal Chemistry. 35: 3319-24. PMID 1382133 DOI: 10.1021/Jm00096A002 |
0.39 |
|
| 1992 |
Palmer AJ, Zeman S, Lodge D. Methohexitone antagonises kainate and epileptiform activity in rat neocortical slices. European Journal of Pharmacology. 221: 205-9. PMID 1330621 DOI: 10.1016/0014-2999(92)90702-6 |
0.365 |
|
| 1992 |
McQuaid LA, Smith EC, Lodge D, Pralong E, Wikel JH, Calligaro DO, O'Malley PJ. 3-Phenyl-4-hydroxyquinolin-2(1H)-ones: potent and selective antagonists at the strychnine-insensitive glycine site on the N-methyl-D-aspartate receptor complex. Journal of Medicinal Chemistry. 35: 3423-5. PMID 1326635 DOI: 10.1021/Jm00096A019 |
0.345 |
|
| 1991 |
Ornstein PL, Schoepp DD, Arnold MB, Leander JD, Lodge D, Paschal JW, Elzey T. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action. Journal of Medicinal Chemistry. 34: 90-7. PMID 1825117 DOI: 10.1021/Jm00105A016 |
0.428 |
|
| 1991 |
Schoepp DD, Smith CL, Lodge D, Millar JD, Leander JD, Sacaan AI, Lunn WH. D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist. European Journal of Pharmacology. 203: 237-43. PMID 1686860 DOI: 10.1016/0014-2999(91)90719-7 |
0.42 |
|
| 1991 |
Lodge D, Jones MG, Palmer AJ. Excitatory amino acids: new tools for old stories or pharmacological subtypes of glutamate receptors: electrophysiological studies. Canadian Journal of Physiology and Pharmacology. 69: 1123-8. PMID 1659489 |
0.434 |
|
| 1991 |
Church J, Millar JD, Jones MG, Lodge D. NMDA receptor antagonist effects of the stereoisomers of beta-cyclazocine in rats, in vivo and in vitro. European Journal of Pharmacology. 192: 337-42. PMID 1647315 DOI: 10.1016/0014-2999(91)90222-C |
0.349 |
|
| 1990 |
Church J, Lodge D. Anticonvulsant actions of phencyclidine receptor ligands: correlation with N-methylaspartate antagonism in vivo. General Pharmacology. 21: 165-70. PMID 2185117 |
0.328 |
|
| 1990 |
Lodge D, Johnson KM. Noncompetitive excitatory amino acid receptor antagonists. Trends in Pharmacological Sciences. 11: 81-6. PMID 2156365 DOI: 10.1016/0165-6147(90)90323-Z |
0.556 |
|
| 1990 |
Lodge D, Collingridge G. Les agents provocateurs: a series on the pharmacology of excitatory amino acids. Trends in Pharmacological Sciences. 11: 22-4. PMID 2155494 DOI: 10.1016/0165-6147(90)90037-9 |
0.497 |
|
| 1990 |
Ornstein PL, Schoepp DD, Leander JD, Wong T, Zimmerman DM, Lodge D. LY233053: a structurally novel, potent and selective competitive N-methyl-D-aspartate receptor antagonist. Progress in Clinical and Biological Research. 361: 429-33. PMID 2149764 |
0.375 |
|
| 1990 |
Schoepp DD, Ornstein PL, Leander JD, Lodge D, Salhoff CR, Zeman S, Zimmerman DM. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action. The Journal of Pharmacology and Experimental Therapeutics. 255: 1301-8. PMID 2148188 |
0.436 |
|
| 1990 |
Jones MG, Anis NA, Lodge D. Philanthotoxin blocks quisqualate-, AMPA- and kainate-, but not NMDA-, induced excitation of rat brainstem neurones in vivo. British Journal of Pharmacology. 101: 968-70. PMID 2085718 |
0.32 |
|
| 1990 |
Beart PM, Lodge D. Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation. The Journal of Pharmacy and Pharmacology. 42: 354-5. PMID 1976785 DOI: 10.1111/J.2042-7158.1990.Tb05426.X |
0.422 |
|
| 1990 |
Church J, Lodge D. Failure of sigma-receptor ligands to reduce the excitatory actions of N-methyl-DL-aspartate on rat spinal neurons in-vivo. The Journal of Pharmacy and Pharmacology. 42: 56-7. PMID 1969952 DOI: 10.1111/j.2042-7158.1990.tb05350.x |
0.327 |
|
| 1990 |
Lodge D, Jones MG. Evidence for glutamate receptor subtypes from in vivo electrophysiology: studies with HA-966, quinoxalinediones and philanthotoxin. Advances in Experimental Medicine and Biology. 268: 101-8. PMID 1963735 |
0.476 |
|
| 1989 |
Aram JA, Martin D, Tomczyk M, Zeman S, Millar J, Pohler G, Lodge D. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 248: 320-8. PMID 2536430 |
0.338 |
|
| 1988 |
Fletcher EJ, Martin D, Aram JA, Lodge D, Honoré T. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro. British Journal of Pharmacology. 95: 585-97. PMID 2906560 |
0.372 |
|
| 1988 |
Lodge D, Davies SN, Jones MG, Millar J, Manallack DT, Ornstein PL, Verberne AJ, Young N, Beart PM. A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists. British Journal of Pharmacology. 95: 957-65. PMID 2905186 DOI: 10.1111/J.1476-5381.1988.Tb11726.X |
0.401 |
|
| 1988 |
Honoré T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science (New York, N.Y.). 241: 701-3. PMID 2899909 DOI: 10.1126/Science.2899909 |
0.541 |
|
| 1988 |
Martin D, Lodge D. Phencyclidine receptors and N-methyl-D-aspartate antagonism: electrophysiologic data correlates with known behaviours. Pharmacology, Biochemistry, and Behavior. 31: 279-86. PMID 2854262 |
0.332 |
|
| 1988 |
Church J, Zeman S, Lodge D. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Anesthesiology. 69: 702-9. PMID 2847595 |
0.384 |
|
| 1988 |
O'Shaughnessy CT, Lodge D. N-methyl-D-aspartate receptor-mediated increase in intracellular calcium is reduced by ketamine and phencyclidine. European Journal of Pharmacology. 153: 201-9. PMID 2846317 |
0.333 |
|
| 1988 |
Davies SN, Martin D, Millar JD, Aram JA, Church J, Lodge D. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands. European Journal of Pharmacology. 145: 141-51. PMID 2832187 |
0.349 |
|
| 1988 |
O'Shaughnessy CT, Aram JA, Lodge D. A1 adenosine receptor-mediated block of epileptiform activity induced in zero magnesium in rat neocortex in vitro. Epilepsy Research. 2: 294-301. PMID 2461856 |
0.348 |
|
| 1987 |
Lewis SJ, Cincotta M, Verberne AJ, Jarrott B, Lodge D, Beart PM. Receptor autoradiography with [3H]L-glutamate reveals the presence and axonal transport of glutamate receptors in vagal afferent neurones of the rat. European Journal of Pharmacology. 144: 413-5. PMID 2894317 DOI: 10.1016/0014-2999(87)90399-2 |
0.403 |
|
| 1986 |
Davies SN, Church J, Blake J, Lodge D, Lessor RA, Rice KC, Jacobson AE. Is Metaphit a phencyclidine antagonist? Studies with ketamine, phencyclidine and N-methylaspartate. Life Sciences. 38: 2441-5. PMID 3014248 DOI: 10.1016/0024-3205(86)90614-4 |
0.353 |
|
| 1985 |
Lodge D, Johnston GA. Effect of ketamine on amino acid-evoked release of acetylcholine from rat cerebral cortex in vitro. Neuroscience Letters. 56: 371-5. PMID 3895050 DOI: 10.1016/0304-3940(85)90271-X |
0.347 |
|
| 1985 |
Spence I, Drew C, Johnston GA, Lodge D. Acute effects of lead at central synapses in vitro. Brain Research. 333: 103-9. PMID 2986766 DOI: 10.1016/0006-8993(85)90129-5 |
0.301 |
|
| 1985 |
Thomson AM, West DC, Lodge D. An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? Nature. 313: 479-81. PMID 2982106 |
0.389 |
|
| 1984 |
Berry SC, Dawkins SL, Lodge D. Comparison of sigma- and kappa-opiate receptor ligands as excitatory amino acid antagonists. British Journal of Pharmacology. 83: 179-85. PMID 6091823 |
0.4 |
|
| 1980 |
Curtis DR, Bornstein JC, Lodge D. In vivo analysis of GABA receptors on primary afferent terminations in the cat. Brain Research. 194: 255-8. PMID 6247036 |
0.323 |
|
| 1979 |
Curtis DR, Lodge D, Bornstein JC. Nuciferine and central glutamate receptors. The Journal of Pharmacy and Pharmacology. 31: 795-7. PMID 41920 |
0.507 |
|
| 1977 |
Martin MR, Lodge D, Headley PM, Biscoe TJ. Pharmacological studies of facial motoneurones in the rat. European Journal of Pharmacology. 42: 291-8. PMID 856610 DOI: 10.1016/0014-2999(77)90296-5 |
0.378 |
|
| 1977 |
Craig CR, Curtis DR, Lodge D. Dual effects of hemicholinium-3 at central cholinergic synapses. The Journal of Physiology. 264: 367-77. PMID 190385 |
0.318 |
|
| 1976 |
Curtis DR, Game CJ, Lodge D. Benzodiazepines and central glycine receptors. British Journal of Pharmacology. 56: 307-11. PMID 1260175 |
0.485 |
|
| 1976 |
Headley PM, Lodge D. The effects of beta-carbolines on responses to acetylcholine, noradrenaline, 5-hydroxytryptamine and amino acids in the rat spinal cord. Brain Research. 101: 479-88. PMID 1244986 DOI: 10.1016/0006-8993(76)90472-8 |
0.304 |
|
| 1976 |
Headley PM, Lodge D. Studies on field potentials and on single cells in the inferior olivary complex of the rat. Brain Research. 101: 445-59. PMID 1244985 DOI: 10.1016/0006-8993(76)90470-4 |
0.333 |
|
| 1976 |
Biscoe TJ, Headley PM, Lodge D, Martin MR, Watkins JC. The sensitivity of rat spinal interneurones and renshaw cells to L-glutamate and L-aspartate. Experimental Brain Research. 26: 547-51. PMID 1010006 DOI: 10.1007/BF00238827 |
0.315 |
|
| 1976 |
Headley PM, Lodge D, Duggan AW. Drug-induced rhythmical activity in the inferior olivary complex of the rat. Brain Research. 101: 461-78. PMID 128400 DOI: 10.1016/0006-8993(76)90471-6 |
0.32 |
|
| 1975 |
Headley PM, Lodge D, Biscoe TJ. Acetylcholine receptors on Renshaw cells of the rat. European Journal of Pharmacology. 30: 252-9. PMID 1079188 DOI: 10.1016/0014-2999(75)90107-7 |
0.5 |
|
| 1975 |
Duggan AW, Headley PM, Lodge D. Acetylcholine-sensitive cells in the caudal medulla of the rat: distribution, pharmacology and effects of pentobarbitone. British Journal of Pharmacology. 54: 23-31. PMID 166717 DOI: 10.1111/j.1476-5381.1975.tb07405.x |
0.337 |
|
| 1974 |
Lodge D, Headley PM, Duggan AW, Biscoe TJ. The effects of morphine, etorphine and sinomenine on the chemical sensitivity and synaptic responses of Renshaw cells and other spinal neurones in the rat. European Journal of Pharmacology. 26: 277-84. PMID 4854802 DOI: 10.1016/0014-2999(74)90238-6 |
0.301 |
|
| 1974 |
Biscoe TJ, Duggan AW, Lodge D. Actions of pancuronium on Renshaw cells of the rat spinal cord. Comparative and General Pharmacology. 4: 179-81. PMID 4770274 DOI: 10.1016/0010-4035(73)90037-2 |
0.446 |
|
| 1973 |
Duggan AW, Lodge D, Biscoe TJ. The inhibition of hypoglossal motoneurones by impulses in the glossopharyngeal nerve of the rat. Experimental Brain Research. 17: 261-70. PMID 4722116 DOI: 10.1007/BF00234665 |
0.392 |
|
| 1973 |
Biscoe TJ, Duggan AW, Lodge D. Antagonism between bicuculline, strychnine, and picrotoxin and depressant amino-acids in the rat nervous system. Comparative and General Pharmacology. 3: 423-33. PMID 4146858 DOI: 10.1016/0010-4035(72)90056-0 |
0.363 |
|
| Show low-probability matches. |